Navigation Links
Hemophiliacs Demand Justice

The Irish government said that it will not sue the US pharmaceutical companies which were accused of providing HIV and hepatitis C contaminated blood and plasma// products to more than 300 hemophiliacs.

Members of the hemophiliac society suffer from sporadic bleeding episodes that destroy joints and damage organs, requiring regular transfusions of blood-clotting products to survive. Tánaiste Mary Harney said that the government will not proceed with the case as it has received expert advice from the Irish attorney general that such a claim would not succeed. The Minister for Health said that although the Government acknowledges the terrible tragedy and wants to render all the help to the Irish Haemophilia Society. Statistics show that about 106 patients were infected with HIV and 221 patients with Hepatitis C.

But the Irish government said that money should be spent on improving the services to persons with haemophilia, including those infected with Hepatitis C and HIV rather than pursuing an inquiry against the pharmaceutical companies. The Irish Haemophilia Society on the other hand wants an enquiry in to this matter. It also claimed these US companies accepted and encouraged blood and plasma donations from high risk donors. Ms Harney mentioned that Armour Cutter Miles, Travenol-Baxter, Immuno International were the three US pharmaceutical companies which were accused in the scandal. Mr O’Mahony said that if legal action was taken in the States against these companies, and was successful then the Irish taxpayer could recoup all of the money spent on providing treatment, medical care and compensation.


'"/>




Page: 1

Related medicine news :

1. High Demand for a child vaccine
2. Demand for universal flu vaccination
3. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
4. Research Fraud By Doctor – Probe Demanded
5. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
6. Bird Flu Likely To Reduce World Energy Demand
7. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
8. Sex Health Clinics Unable To Meet Increasing Demand
9. Bird Flu Scare Does Not Reduce Demand For Chicken
10. Demand For Diet Drugs On The Rise
11. High Demand For Circumcision In AIDS-Hit Swaziland
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... , ... January 19, 2017 , ... ... a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus ... condensed version of the clinic’s leading recovery program. , “We know it’s ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is ... modern CTMS workflow designed to seamlessly integrate and streamline the way researchers prepare ... single page, maximizing usability and improving efficiency significantly for users – a first ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... 19, 2017 , ... Rountree Brady Insurance Agency, a Savannah ... eastern Georgia, is embarking on a charity effort to raise awareness and gather ... every year than anything else, yet risk factors associated with heart disease are ...
(Date:1/19/2017)... ... 2017 , ... Attorney Robert “RC” Pate , founder of The Law ... Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. ... the effect of the critical funding gap for research into pediatric cancer research. From ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... Wound care is $2 5 billion ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ... Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for the ...
(Date:1/19/2017)... 18, 2017   Synthetic Biologics, Inc. ... therapeutics designed to preserve the microbiome to protect ... plans to initiate a Phase 2b/3 adaptive pivotal ... lovastatin lactone designed to reduce methane production by ... gut to treat the underlying cause of irritable ...
(Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
Breaking Medicine Technology: